- Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
Nouvelle revue francaise d'hematologie (1993-02-01)
J L Binet
PMID7685518
摘要
The review of Phase II trials in patients treated by Fludarabine phosphate (Fludara I.V) has been demonstrated to have unequivocal benefit for some patients with Chronic Lymphocytic Leukemia (CLL) non Hodgkin lymphoma and macroglobulinemia. Comparison of Fludara I.V with other treatment regimens is now studied in randomised protocols for B and C stages of CLL.